WuXi Biologics

WuXi Biologics is a leading global CRDMO providing end-to-end biologics solutions from concept to commercialization. As of June 30, 2025, we are supporting 864 integrated projects, including 24 in commercial manufacturing.
Our specialized small-scale GMP production platform offers flexible protein production services tailored for targeted radiotherapeutics and in vivo diagnostics. We reliably produce diverse formats -including antibodies, bispecific antibodies, and antibody fragments -with accelerated timelines and robust quality assurance to advance your programs efficiently.
www.wuxibiologics.com